Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | LYELL IMMUNOPHARMA INC LYEL | BlackRock, Inc. BLK | 715,111 5.700% | 715,111 (New Position) | Filing History |
| 2023-02-13 5:02 pm Sale | 2022-12-31 | 13G | LYELL IMMUNOPHARMA INC LYEL | Foresite Capital Fund IV, L.P. | 500,000 4.000% | -164,109 (-24.71%) | Filing History |
| 2023-02-09 11:25 am Purchase | 2022-12-30 | 13G | LYELL IMMUNOPHARMA INC LYEL | VANGUARD GROUP INC | 629,562 5.050% | 629,562 (New Position) | Filing History |
| 2022-02-14 4:17 pm Purchase | 2021-12-31 | 13G | LYELL IMMUNOPHARMA INC LYEL | MWG Management Ltd. | 1,008,117 8.380% | 1,008,117 (New Position) | Filing History |
| 2022-02-14 4:10 pm Purchase | 2021-12-31 | 13G | LYELL IMMUNOPHARMA INC LYEL | Newton (PTC) Limited | 754,698 6.280% | 754,698 (New Position) | Filing History |
| 2022-02-14 12:04 pm Purchase | 2021-12-31 | 13G | LYELL IMMUNOPHARMA INC LYEL | ARCH Venture Fund IX, L.P. | 1,820,636 15.100% | 1,820,636 (New Position) | Filing History |
| 2022-02-11 3:10 pm Purchase | 2021-12-31 | 13G | LYELL IMMUNOPHARMA INC LYEL | Foresite Capital Fund IV, L.P. | 664,109 5.500% | 664,109 (New Position) | Filing History |
| 2022-02-10 4:51 pm Purchase | 2021-12-31 | 13G | LYELL IMMUNOPHARMA INC LYEL | GSK plc | 1,512,659 12.600% | 1,512,659 (New Position) | Filing History |